Advertisement
U.S. markets open in 6 hours 27 minutes

Telix Pharmaceuticals Limited (TLPPF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
14.00-0.10 (-0.71%)
At close: 03:00PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 4.92B
Enterprise Value 4.86B
Trailing P/E 144.64
Forward P/E 66.67
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)11.13
Price/Book (mrq)17.82
Enterprise Value/Revenue 11.71
Enterprise Value/EBITDA 102.25

Trading Information

Stock Price History

Beta (5Y Monthly) 2.38
52-Week Change 3133.33%
S&P500 52-Week Change 331.18%
52 Week High 315.75
52 Week Low 36.00
50-Day Moving Average 314.27
200-Day Moving Average 311.59

Share Statistics

Avg Vol (3 month) 33.75k
Avg Vol (10 day) 33.65k
Shares Outstanding 5334.68M
Implied Shares Outstanding 6351.38M
Float 8282.35M
% Held by Insiders 141.43%
% Held by Institutions 117.99%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in AUD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 7.62%
Operating Margin (ttm)9.49%

Management Effectiveness

Return on Assets (ttm)7.97%
Return on Equity (ttm)20.49%

Income Statement

Revenue (ttm)645.68M
Revenue Per Share (ttm)1.99
Quarterly Revenue Growth (yoy)58.10%
Gross Profit (ttm)N/A
EBITDA 73.14M
Net Income Avi to Common (ttm)49.19M
Diluted EPS (ttm)0.10
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)118.84M
Total Cash Per Share (mrq)0.36
Total Debt (mrq)22.14M
Total Debt/Equity (mrq)5.48%
Current Ratio (mrq)0.99
Book Value Per Share (mrq)1.21

Cash Flow Statement

Operating Cash Flow (ttm)49.71M
Levered Free Cash Flow (ttm)105.93M